Skip to main content Skip to footer

Driving digital in biopharma: Podcast

Tune in to industry innovators sharing real experiences – turning digital potential into a competitive advantage and improving patient outcomes.

Subscribe:

    

Tech + AI & Data = Innovative medicine for patients

In this insightful episode of Driving Digital in Biopharma, host Tom Lehmann explores with Áine Hanly, Chief Technology Officer at Vir Biotechnology, the transformative role of data and technology in drug development and manufacturing. Áine delves into the advancements in data accessibility and automation, such as single-cell manipulation and high throughput processes, which have notably shortened cycle times and boosted efficiency. She also discusses the innovative use of the Vir AI tool Daisy for antibody design and optimization, which speeds up the process and enhances manufacturability. The episode wraps up by highlighting the critical importance of a robust data strategy and the power of cross-functional partnerships in fostering innovation and operational efficiency across the biopharma industry.

Contributors:

Tom Lehmann

Managing Director – Life Sciences, Global R&D Lead

Áine Hanly

Chief Technology Officer – Vir Biotechnology

Inflection point: Transforming today’s labs for the future

This episode of Driving Digital in Biopharma offers a peek into the digital revolution brewing in the biopharma labs, courtesy of Richard Milne, the Vice-president and general manager of Digital Science Solutions at Thermo Fisher Scientific. From e-commerce roots to pioneering digital science, Richard and Tom delve into the vision for laboratories, and the integration of artificial intelligence and automation in scientific research and lab operations. Their conversation highlights the critical role of digital strategies in enhancing productivity and accelerating scientific advancements. Richard also gives his insights on the future potential of automation and robotics in laboratories, alongside the challenges and opportunities that AI presents in revolutionizing the drug discovery process.

Contributors:

Tom Lehmann

Managing Director – Life Sciences, Global R&D Lead

Richard Milne

Vice-president and General Manager of Digital Science Solutions – Thermo Fisher Scientific

Unlocking growth: Digital innovation in commercial manufacturing

In this episode of "Driving Digital in Biopharma," host Tom Lehmann welcomes Morrey Atkinson, the Chief Technology and Operations Officer at Vertex Pharmaceuticals. With a rich background in process development and manufacturing within the pharmaceutical industry, Morrey shares his insights on Vertex's strategic evolution and its commitment to serial innovation through substantial investments in R&D. They discuss the company’s modality-agnostic approach, which allows flexibility in tackling various diseases, as well as covering the strategic use of contract development and manufacturing organizations (CDMOs) to optimize Vertex's global manufacturing footprint, ensuring rapid and reliable delivery of therapies to patients worldwide.

Listeners will gain a comprehensive understanding of how Vertex Pharmaceuticals leverages digital innovation to maintain its leadership in drug development and manufacturing, setting new standards in the biopharma industry

Contributors:

Tom Lehmann

Managing Director – Life Sciences, Global R&D Lead

Morrey Atkinson

Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations, Vertex Pharmaceuticals

Driving digital in biopharma podcasts

Life Sciences

Innovating oncology patient experience with data, digital & tech

Tom Lehmann talks with Samer Ansari, Head of Data, Digital, and Technology at Takeda Oncology to discuss the role of digital in creating exceptional HCP and patient experiences.

LISTEN TO THE EPISODE
Life Sciences

Harmonizing digital, data and traditional ways of working

Tom Lehmann talks with Chris Braithwaite, Novartis about the delicate balance required between traditional methods, rapidly emerging technology, and human decision-making to achieve digital transformation in biopharma.

LISTEN TO THE EPISODE
Life Sciences

Design for the future and deliver progress over perfection

Tom Lehmann talks with Micheal Rider, GSK about modernizing digital, data, and analytics capabilities across Development to  focus on near-term wins while planning for the future.

LISTEN TO THE EPISODE
Life Sciences

Rethink it: Digital is not a thing, digital is a means

Tom Lehmann  discusses the important of a strong digital core when evolving operation in biopharma with Jason Bronfeld, Head of Product Development IT, BMS.

LISTEN TO THE EPISODE
Life Sciences

Enabling tomorrow’s science through digital

Tom Lehmann talks with Anders Persson, AstraZeneca, about the role of digital and data in the transformation of global drug development.

LISTEN TO THE EPISODE
Life Sciences

Decentralized methods and the future of clinical research

Host Tom Lehmann talks with Craig Lipset, a long-time advocate and inspiring innovator in the clinical research and medicine development community.

LISTEN TO THE EPISODE
Life Sciences

Digital is greater than technology

Tom Lehmann discusses digital strategy and transformation wins with Guido Radack, Vice President, Strategic Initiatives Leader at Bayer.

LISTEN TO THE EPISODE
Life Sciences

From documents to data - Regulatory's future?

Tom and guest Eddie Reilly, Sanofi discuss delivering new therapies to patients more efficiently and how that’s enabled by regulatory affairs.

LISTEN TO THE EPISODE
Life Sciences

In search of the digital thread

Host Tom Lehmann talks with John Kelleher, head of digital quality for Pfizer global supply. John shares insights on connecting learnings and impacts of a digital QA transformation pilot to a more holistic QC transformation initiative.

LISTEN TO THE EPISODE
Life Sciences

Raising the innovation bar in early research and development

Lars and Tom discuss the journey to accelerate research and early development through lab automation...

LISTEN TO THE EPISODE
Life Sciences

Enabling scientific curiosity through digital in drug recovery

Tom and guest Julie Huxley-Jones, GSK, discuss the mindset of scientific curiosity, innovation and collaboration and its role on the impact of digital in scientific discovery.

LISTEN TO THE EPISODE
Life Sciences

Data is the new currency for drug development

Venkat and Tom discuss the critical role of data, design and digital and creating value with patients.

LISTEN TO THE EPISODE
Life Sciences

Digital at the pace of science

Kailash and Tom discuss strategy, how digital is improving patient health, the pace of technology, and future vision.

LISTEN TO THE EPISODE
Life Sciences

A human health care philosophy and digital transformation

Stephen and Tom talk about how Eisai’s focus on human health care is shaping the company’s digital approach.

LISTEN TO THE EPISODE
Life Sciences

Decentralized clinical research

Craig and Tom discuss priorities for clinical trial access and decentralized research methods.

LISTEN TO THE EPISODE
Life Sciences

In search of the digital thread

John and Tom talk about learnings from a digital transformation pilot and improving process.

LISTEN TO THE EPISODE
Life Sciences

The 4 P’s of digital transformation

Debraj and Tom discuss the enabling role of 4 P’s in a successful digital transformation.

LISTEN TO THE EPISODE
Life Sciences

Digital’s positive role in patient health

Tina, Jennifer and Tom discuss the COVID-19 patient-care reset.

LISTEN TO THE EPISODE
Life Sciences

Digital is greater than technology

Guido and Tom discuss clinical innovation, technology investment, decentralized trials and COVID’s role.

LISTEN TO THE EPISODE
Life Sciences

Digital at the pace of science

Kailash and Tom discuss strategy, how digital is improving patient health, the pace of technology, and future vision.

LISTEN TO THE EPISODE
Life Sciences

Digitalization in Biopharma R&D

Join Tom and Katie Miinch for the discussion that ignited our series!

LISTEN TO THE EPISODE

Meet the host

Tom Lehmann
Managing Director – Life Sciences

"It’s fascinating to connect with people in the middle of shaping and delivering transformation, learning about the challenges and opportunities they are experiencing."

I’ve spent the past 25 years working with biopharmaceutical companies across the R&D value chain to understand and address their critical business challenges. During this time, I’ve seen technology (and now digital) evolve from being viewed as an enabler and cost center into something that is now a core part of the dialog to solve the most complex challenges faced by the industry. That evolution was a large part of the decision to start a podcast series that explores the state of digital transformation in the biopharmaceutical industry.